Detection of precancerous cervical lesions is differential by human papillomavirus type

Cancer Research

Volumn 69, Issue 8, 2009, Pages 3262-3266

  Safaeian, Mahboobeh ^a   Schiffman, Mark ^a   Gage, Julia ^a   Solomon, Diane ^a   Wheeler, Cosette M ^b   Castle, Philip E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CARCINOGENIC ACTIVITY; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 65949110864     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4192     Document Type: Article

References (17)

1. Clifford GM, Smith JS, Aguado T, Francesehi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-5. (Pubitemid 36897943)
2. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis, Br J Cancer 2003; 88: 63-73. (Pubitemid 36241220)
3. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121: 621-32. (Pubitemid 46986496)
4. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10- year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97: 1072-9. (Pubitemid 41417924)
5. Lorincz AT, Reid R, Jenson AR, Greenberg MD, Lancaster W, Kurman Rj. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79: 328-37.
6. Kovacic MB, Castle PE, Herrero R, et al. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res 2006; 66: 10112-9. (Pubitemid 44672065)
7. Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005; 337: 76-84. (Pubitemid 40725441)
8. Schiffman M, Adrianza ME. ASCUS-LS1L Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 2000; 44: 726-42.
9. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000; 92: 397-402.
10. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am j Obstet Gynecol 2003; 188: 1393-400. (Pubitemid 36741264)
11. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383-92. (Pubitemid 36741263)
12. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293-9. (Pubitemid 32219816)
13. Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006; 108: 264-72. (Pubitemid 44305665)
14. Castle PE, Cox JT, Jeronimo J, et al. An analysis of high-risk human papillomavirus DKA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstet Gynecol 2008; 111: 847-56.
15. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses, J Clin Microbiol 2000; 38: 357-61. (Pubitemid 30043317)
16. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001; 183: 1554-64. (Pubitemid 32466692)
17. Jeronimo J, Massad LS, Schiffman M. Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type. Am J Obstet Gynecol 2007; 197: 47-8. (Pubitemid 47001848)